Medtronic cuts accused doctor loose

U.S. Sen. Charles Grassley expressed concern that a list of consultants provided to him by Medtronic doesn't include a doctor accused of falsifying data in a favorable study of the company's Infuse bone-graft product. Meanwhile, the device maker said Wednesday it had suspended its consulting agreement with the former military doctor accused by the Army of faking that research. Report | Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.